Central Hospital, Nancy, France: Inflammatory Bowel Diseases trials

The registry lists 12 Inflammatory Bowel Diseases studies with Central Hospital, Nancy, France as lead sponsor. 2 are open to participants now and 0 have results posted.

No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted TherapiesRecruitingNCT05456893
• IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASERecruitingNCT03809728Not applicable
• Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative ColitisCompletedNCT06449820
• Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease PatientsCompletedNCT05927064
• Transcriptomic Study of IBD-associated Colorectal CancerCompletedNCT05060770
• Ocular Manifestations of Inflammatory Bowel DiseaseCompletedNCT04771039
• Prevalence of Respiratory Impairment During IBDStatus unknownNCT04225650
• Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBDStatus unknownNCT04180345
• Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel DiseaseStatus unknownNCT03648398Not applicable
• An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University HospitalCompletedNCT03248024
• Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel DiseasesStatus unknownNCT02878395
• Prevalence of Keratoconus in Inflammatory Bowel DiseasesCompletedNCT02861339Not applicable